A brief note on randomized controlled trials and compassionate/off-label use of drugs in the early phases of the COVID-19 pandemic

A brief note on randomized controlled trials and compassionate/off-label use of drugs in the early phases of the COVID-19 pandemic

Randomized controlled trials (RCTs) are the best way to find effective and acceptable safe treatments for COVID-19 and any possible future outbreak. However, caution is needed when comparing the number of participants in RCTs with that of patients with COVID-19 treated with compassionate and/or off-...

Full description

Bibliographic Details
Main Authors: Matteo Bassetti, Paolo Pelosi, Chiara Robba, Antonio Vena, Daniele Roberto Giacobbe
Format: Article
Language:English
Published: BioExcel Publishing Ltd 2020-05-01
Series:Drugs in Context
Subjects:
compassionate
coronavirus
covid-19
off-label
rct
sars-cov-2
Online Access:https://www.drugsincontext.com/a-brief-note-on-randomized-controlled-trials-and-compassionate-off-label-use-of-drugs-in-the-early-phases-of-the-covid-19-pandemic

Internet

https://www.drugsincontext.com/a-brief-note-on-randomized-controlled-trials-and-compassionate-off-label-use-of-drugs-in-the-early-phases-of-the-covid-19-pandemic

Similar Items